TITLE

Preoperative Chemoradiation in the Management of Adenocarcinoma of the Body of the Pancreas

AUTHOR(S)
Arnoletti, Juan P.; Hoffman, John P.; Kagan, Steven A.; Eisenberg, Burton; Ross, Eric A.; Meropol, Neal J.; Freedman, Gary
PUB. DATE
April 2002
SOURCE
American Surgeon;Apr2002, Vol. 68 Issue 4, p330
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Adenocarcinoma of the body of the pancreas has been traditionally associated with low resectability and poor prognosis. We reviewed 30 consecutive cases of pancreatic body adenocarcinoma presenting between 1988 and 2001. Twenty-six (87%) patients received preoperative chemotherapy (either 5-fluorouracil with or without mitomycin C or gemcitabine) plus radiation therapy (50.4 Gy), and four patients received chemoradiation postoperatively. During or shortly after chemoradiation 16 (53%) patients developed distant metastasis (n = 12), tumor progression (n = 2), or fatal septic complications (n = 2). Fourteen patients underwent surgical resection with curative intent. Resections performed included distal subtotal pancreatectomies (n = 6), extended pancreaticoduodenectomies (n = 6), and total pancreatectomies (n = 2). Ten patients (71%) required vascular reconstruction as a result of involvement of the portal vein or the superior mesenteric, hepatic arterial, or celiac vessels. Median overall survival was 34 months (range 8-152) for the resected group as compared with 8 months (range 1-14) in the unresected group (P = 0.005). Five-year actuarial overall survival is projected at 45 per cent for the resected group. In this poor-prognostic subset of patients with pancreatic cancer preoperative chemoradiation followed by an aggressive surgical approach was associated with resectability and long-term survival of a significant minority of patients.
ACCESSION #
6596548

 

Related Articles

  • Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. V Gebbia; E Maiello; F Giuliani; N Borsellino; M Caruso; G Di Maggio; F Ferraù; R Bordonaro; F Verderame; P Tralongo; L Di Cristina; R Agueli; P Russo; G Colucci // Annals of Oncology;Jul2007 Supplement 6, Vol. 18, pvi124 

    Background: In daily clinical practice second-line chemotherapy (SLCT) is frequently given to patients with advanced pancreatic cancer failing gemcitabine-based first-line chemotherapy without solid scientific support. Patients and methods: A retrospective survey was carried out including 42...

  • Prognostic Impact of Para-aortic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto, Yasushi; Yuasa, Yoshio; Sueda, Taijiro // World Journal of Surgery;Aug2010, Vol. 34 Issue 8, p1900 

    The aim of the present study was to clarify the prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. Medical records of 103 consecutive patients with pancreatic ductal adenocarcinoma, who underwent pancreatic resection with regional and para-aortic lymph...

  • Capecitabine.  // Reactions Weekly;4/28/2007, Issue 1149, p9 

    The article presents a case study involving a 43-year-old man who developed pancolitis after receiving oral capecitabine for treatment of metastatic pancreatic adenocarcinoma. It references a study by J. P. Dutcher et al published by the April 2007 issue of the "International Journal of...

  • An Early Phase II Study of S-1 in Patients with Metastatic Pancreatic Cancer. Ueno, Hideki; Okusaka, Takuji; Ikeda, Masafumi; Takezako, Yoriko; Morizane, Chigusa // Oncology;2005, Vol. 68 Issue 2/3, p171 

    Objective: The aim of this study was to evaluate the efficacy and toxicity of S-1 in patients with metastatic pancreatic cancer. Methods: Patients were required to have a histological diagnosis of pancreatic adenocarcinoma with measurable metastatic lesions, and no prior chemotherapy. S-1 was...

  • Bevacizumab.  // Reactions Weekly;9/1/2007, Issue 1167, p8 

    The article presents a case study of a 53-year old man with adenocarcinoma of the colon and has developed nasal septum perforation and fusariosis during treatment with bevacizumab for unresectable lung progression. The man started an LV5FU2 chemotherapy regimen and afterwards reported occasional...

  • THE INFLUENCE OF CHEMOTHERAPEUTIC AGENTS ON THE EXPRESSION OF HUMAN MULTIDRUG RESISTANCE PROTEIN (ABCC, ABCB) FAMILY MEMBERS IN VITRO IN DIFFERENT PANCREATIC CANCER CELL LINES.  // European Surgical Research;Jul2006 Supplement 1, Vol. 38, p112 

    An abstract of the article "The Influence of Chemotherapeutic Agents on the Expression of Human Multidrug Resistance Protein (ABCC, ABCB) Family Members In Vitro in Different Pancreatic Cancer Cell Lines," by S. Eisold and colleagues, published in an issue of the "European Surgical Research"...

  • Enhancement of Gemcitabine-Induced Apoptosis by Restoration of p53 Function in Human Pancreatic Tumors. Cascalló, Manel; Calbó, Joaquim; Capellà, Gabriel; Fillat, Cristina; Pastor-Anglada, Marçal; Mazo, Adela // Oncology;2005, Vol. 68 Issue 2/3, p179 

    Human pancreatic adenocarcinomas are highly resistant to conventional treatment modalities, specially to chemotherapy. Among the genes that modulate apoptosis in response to cytotoxic drugs, the role of p53 has been demonstrated to be of paramount importance. Moreover, p53 is mutated in close to...

  • Appendiceal Cancer and Peritoneal Carcinomatosis: A Report of 29 Cases. Esquivel, Jesus; Merriman, Barry; Davis, Sallie; Manning, Darrell // American Surgeon;Aug2006, Vol. 72 Issue 8, p714 

    Peritoneal surface malignancies of appendiceal origin arise from a perforated neoplasm with gradual expansion of the tumor within the abdomen. We report our experience with 29 patients. Between February 2000 and November 2004, 29 patients were classified into one of three groups based on the...

  • Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. Cronin-Fenton, Deirdre P.; Mooney, Margaret M.; Clegg, Limin X.; Harlan, Linda C.; El-Omar, Emad M.; Rampone, Bernardino; Vaira, Dino; Nakamura, Shotaro // World Journal of Gastroenterology;5/28/2008, Vol. 14 Issue 20, p3165 

    AIM: To examine the extent of use of specific therapies in clinical practice, and their relationship to therapies validated in clinical trials. METHODS: The US National Cancer Institutes' Patterns of Care study was used to examine therapies and survival of patients diagnosed in 2001 with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics